Liontrust Investment Partners’s Maravai LifeSciences MRVI Stock Holding History

Liontrust Investment Partners’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-61,733	Closed	-$336K	–	252
2024 Q4	$336K	Buy	61,733 +17,888	+41%	+$115K	﹤0.01%	199
2024 Q3	$314K	Hold	43,845	–	–	﹤0.01%	197
2024 Q2	$314K	Buy	43,845 +5,628	+15%	+$48.6K	﹤0.01%	197
2024 Q1	$331K	Buy	38,217 +15,354	+67%	+$104K	﹤0.01%	176
2023 Q4	$150K	Sell	22,863 -737	-3%	-$4.76K	﹤0.01%	189
2023 Q3	$236K	Hold	23,600	–	–	﹤0.01%	186
2023 Q2	$293K	Sell	23,600 -800	-3%	-$10.8K	﹤0.01%	202
2023 Q1	$342K	Buy	+24,400	New	+$350K	0.01%	187

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

MFS

Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Liontrust Investment Partners's MRVI Position: Q1 2025 in Review

Liontrust Investment Partners sold out of Maravai LifeSciences (MRVI) in Q1 2025, closing a stake of 61,733 shares — an estimated $336K sold.

Liontrust Investment Partners first reported a position in MRVI in Q1 2023 and held it in 8 quarters. The position peaked at $342K in Q1 2023. 184 funds tracked by Wall St. Rank hold MRVI as of Q1 2025.

Liontrust Investment Partners reported no remaining Maravai LifeSciences position as of Q1 2025 after selling out during the quarter.
Liontrust Investment Partners sold 61,733 Maravai LifeSciences shares in Q1 2025, an estimated $336K.
Liontrust Investment Partners first reported a position in Maravai LifeSciences in Q1 2023 and held it in 8 quarters.
Liontrust Investment Partners's Maravai LifeSciences position peaked at $342K in Q1 2023.
184 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2025.

Based on Liontrust Investment Partners's 13F filing for Q1 2025, filed 13 May 2025.